As of 2026-07-19, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 48.66 mil USD. AXDX's TTM EBITDA according to its financial statements is -32.50 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 16.7x | 15.6x |
| Forward P/E multiples | 17.3x - 21.6x | 19.4x |
| Fair Price | (74.15) - (71.78) | (74.74) |
| Upside | -218186.6% - -211222.1% | -219927.8% |
| Date | EV/EBITDA |